Urokinase Receptor Deficiency Accelerates Renal Fibrosis in Obstructive Nephropathy
- 1 May 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 14 (5) , 1254-1271
- https://doi.org/10.1097/01.asn.0000064292.37793.fb
Abstract
The urokinase cellular receptor (uPAR) recognizes the N-terminal growth factor domain of urokinase-type plasminogen activator (uPA) and is expressed by several cell types. The present study was designed to test the hypothesis that uPAR regulates the renal fibrogenic response to chronic injury. Groups of uPAR wild-type (+/+) and deficient (−/−) mice were investigated between 3 and 14 d after unilateral ureteral obstruction (UUO) or sham surgery. Not detected in normal kidneys, uPAR mRNA was expressed in response to UUO in the +/+ mice. By in situ hybridization, uPAR mRNA transcripts were detected in renal tubules and interstitial cells of the obstructed uPAR+/+ kidneys. The severity of renal fibrosis, based on the measurement of total collagen (13.5 ± 1.5 versus 9.8 ± 1.0 μg/mg kidney on day 14; −/− versus +/+) and interstitial area stained by Masson trichrome (22 ± 4% versus 14 ± 3% on day 14; −/− versus +/+) was significantly greater in the uPAR−/− mice. In the absence of uPAR, renal uPA activity was significantly decreased compared with the wild-type animals after UUO (62 ± 20 versus 135 ± 13 units at day 3 UUO; 74 ± 17 versus 141 ± 16 at day 7 UUO; 98 ± 20 versus 165 ± 10 at day 14 UUO; −/− versus +/+). In contrast, renal expression of several genes that regulate plasmin activity were similar in both genotypes, including uPA, tPA, PAI-1, protease nexin-1, and α2-antiplasmin. Worse renal fibrosis in the uPAR−/− mice appears to be TGF-β-independent, as TGF-β activity was actually reduced by 65% in the −/− mice despite similar renal TGF-β1 mRNA levels. Significantly lower levels of the major 2.3-kb transcript and the 69-kd active protein of hepatocyte growth factor (HGF), a known anti-fibrotic growth factor, in the uPAR−/− mice suggests a potential link between HGF and the renoprotective effects of uPAR. These data suggest that renal uPAR attenuates the fibrogenic response to renal injury, an outcome that is mediated in part by urokinase-dependent but plasminogen-independent functions. E-mail: allison.eddy@seattlechildrens.orgKeywords
This publication has 51 references indexed in Scilit:
- The Low Density Lipoprotein Receptor-related Protein Mediates Fibronectin Catabolism and Inhibits Fibronectin Accumulation on Cell SurfacesPublished by Elsevier ,2002
- t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritisKidney International, 2001
- Role of Apoptosis and Bcl-2/Bax in the Development of Tubulointerstitial Fibrosis during Experimental Obstructive NephropathyNephron Experimental Nephrology, 2001
- Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failureKidney International, 2000
- Modulation of β-Amyloid Precursor Protein Processing by the Low Density Lipoprotein Receptor-related Protein (LRP)Journal of Biological Chemistry, 2000
- ACTIVATION OF THE SERINE PROTEINASE SYSTEM IN CHRONIC KIDNEY REJECTION1Transplantation, 1998
- Soluble latent membrane-type 1 matrix metalloprotease secreted by human mesangial cells is activated by urokinaseKidney International, 1998
- uPA, uPAR, PAI-I: Key intersection of proteolytic, adhesive and chemotacfic highways?Immunology Today, 1997
- Receptor binding and degradation of urokinase-type plasminogen activator by human mesangial cellsKidney International, 1994
- Comparative electrophoretic analysis of human and porcine plasminogen activators in sds-polyacrylamide gels containing plasminogen and caseinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1983